CanSinoBIO's mRNA COVID-19 vaccine candidate cleared for trials in China - CNA

4/3/2022 12:00:00 AM3 years 11 months ago

BEIJING: Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday (Apr 4) that its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's medical products regulator to enter clinical trials. Unl…

BEIJING: Chinese vaccine developer CanSino Biologics Inc (CanSinoBIO) said on Monday (Apr 4) that its potential COVID-19 vaccine using the messenger RNA (mRNA) technology has been approved by China's… [+814 chars]

full article...